Skip to main content
Hauptrubriken
Zeitschriften Fortbildung Hebammen Bücher Kongresse & Live-Webinare
Social Media - Folgen Sie uns!
Instagram Facebook LinkedIn Instagram Hebammen
Service
Jobbörse Kundenservice Info & Hilfe
Fokus-Themen
Chronisch-entzündliche Darmerkrankung COVID-19-Update Diabetes Hautpflege Klima & Gesundheit Hygiene Intensivpflege Kardiologische Pflege Mobilisation Nachhaltigkeit Nierenerkrankungen Obstipation Onkologische Pflege Palliativpflege Schmerz Sucht in der Pflege Vielfalt, Gleichberechtigung und Inklusion Wundversorgung
Erweiterte Suche
Anmelden
nach oben
Zeitschrift für Gerontologie und Geriatrie
Erschienen in:

01.08.2012 | Beiträge zum Themenschwerpunkt

Tools in polypharmacy

Current evidence from observational and controlled studies

verfasst von: Dr. P. Dovjak

Erschienen in: Zeitschrift für Gerontologie und Geriatrie | Ausgabe 6/2012

Einloggen, um Zugang zu erhalten

Abstract

Increasing evidence in managing polypharmacy in the growing elderly population with a higher prevalence of multiple chronic disease is the basis for this paper. Poor adherence, drug–drug interactions, drug–disease interactions, and inappropriate medication challenge the prescriptions of health care providers in this group of patients. Risk factors, the prevalence of polypharmacy, and the impact on health issues will be shown by analyzing the recent literature. Based on intervention trials, several tools in polypharmacy have emerged as practical guides for clinical practice or for the geriatric ward to solve this problem. The Medication Appropriateness Index (MAI) and national lists of potentially inappropriate medication used in clinical practice are presented, including Screening Tool to Alert Doctors to the Right Treatment (START), Screening Tool of Older Persons’ Potentially Inappropriate Prescriptions (STOPP), and Assess, Comprehensive Geriatric Assessment, Adherence, Development, Emergence, Minimization, Interdisciplinarity, Alertness (ACADEMIA).
Vorheriger Artikel Polypharmacy and incontinence
Nächster Artikel Polypharmacy in the elderly from the clinical toxicologist perspective
Literatur
1.
Bain KT, Holmes HM, Beers MH et al (2008) Discontinuing medications: a novel approach for revising the prescribing stage of the medication-use process. J Am Geriatr Soc 56:1946–1952PubMedCrossRef
2.
Barry PJ, Gallagher P, Ryan C et al (2007) START (screening tool to alert doctors to the right treatment)an evidence-based screening tool to detect prescribing omissions in elderly patients. Age Ageing 36:632–638PubMedCrossRef
3.
Campanielli CM (2012) The American Geriatrics Society. American Geriatrics Society updated Beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 60:616–631CrossRef
4.
Carey EC, Covinsky KE, Lui LY et al (2008) Prediction of mortality in community-living frail elderly people with long-term care needs. J Am Geriatr Soc 56:68–75PubMedCrossRef
5.
Chumney EC, Robinson LC (2006) The effect of pharmacist interventions on patients with polyphamacy. Pharm Pract 4:103–109
6.
Dovjak P, Sommeregger U, Otto R et al (2010) Polypharmazie in der Kardiologie—ein beachtliches Problem bei Synkopen, QT-Zeit-Verlangerung, Bradykardie und Tachykardie. Wien Med Wochenzeitschr 160:264–69CrossRef
7.
Elsawy B, Higgins KE (2011) The geriatric assessment. Am Fam Physician 83:48–56PubMed
8.
Gallagher P, O’Mahony D (2008) STOPP (Screening Tool of Older Persons’ potentially inappropriate Prescriptions): application to acutely ill elderly patients and comparison with Beer’s criteria. Age Ageing 37:673–679PubMedCrossRef
9.
Gandhi TK, Weingart SN, Borus J et al (2003) Adverse drug events in ambulatory care. N Engl J Med 16:1556–1564CrossRef
10.
Gosch M, Böhmdorfer B, Benvenuti Falger U et al (2010) Polypharmazie und Schmerztherapie. Wien Med Wochenzeitschr 160:286–292CrossRef
11.
Hanlon JT, Schmader KE, Koronkowski MJ et al (1997) Adverse drug events in high risk older outpatients. J Am Geriatr Soc 370:185–191
12.
Hanlon JT, Schmader KE, Samsa GP et al (1992) A method for assessing drug therapy appropriateness. J Clin Epidem 45:1045–1051CrossRef
13.
Hauptverband der österreichischen Sozialversicherungsträger (2012) Die österreichische Sozialversicherung in Zahlen. Available at: http://​www.​sozialversicheru​ng.​at.​ Accessed 20 June 2012
14.
Holt S, Schmiedl S, Thürmann PA (2010) Potentiell inadäquate Medikation für ältere Menschen: Die PRISCUS Liste. Dtsch Ärztebl 107:543–551
15.
Hovstadius B, Astrand B, Petersson G (2010) Assessment of regional variation in polypharmacy. Pharmocoepidemiol Drug Saf 19:375–383
16.
Iglseder B, Dovjak P, Benvenuti-Falger U et al (2010) Medikamenten-induzierte Delirien älterer Menschen, Wien Med Wochenzeitschr 160:281–285
17.
LaMantia MA, Scheunemann LP, Viera AJ et al (2010) Interventions to improve transitional care between nursing homes and hospitals: a systematic review. J Am Geriatr Soc 58:777–782PubMedCrossRef
18.
Mann E, Böhmdorfer B, Frühwald T et al (2012) Potentially inappropriate medication in geriatric patients: the Austrian consensus panel list. Wien Klin Wochenschr 124:160–169PubMedCrossRef
19.
Naranjo CA, Busto U, Sellers EM et al (1981) A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30:239–245PubMedCrossRef
20.
Onder G, Petrovic M, Tangiisuran B et al (2010) Development and validation of a score to assess risk of adverse drug reactions among in-hospital patients 65 years of older. Arch Intern Med 170:1142–1148PubMedCrossRef
21.
22.
Scott IA, Gray LC, Martin JH et al (2012) Minimizing inappropriate medication in older populations: a ten-step conceptual framework. Am J Med 125:529–537PubMedCrossRef
23.
Sommeregger U et al (2011) Österreichisches Geriatrisches Basisassessment. Österreichische Gesellschaft für Geriatrie und Geronotologie, Apollogasse 19,1070 Wien
24.
Sommeregger U, Iglseder B, Böhmdorfer B et al (2010) Polypharmazie und Stürze im Alter. Wien Med Wochenzeitschr 160:293–296CrossRef
25.
Spinewine A, Schmader KE, Barber N et al (2007) Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet 370:173–84PubMedCrossRef
26.
Steinman MA, Handler SM, Gurwitz JH et al (2011) Beyond the prescription: medication monitoring and adverse drug events in older adults. J Am Geriatr Soc 59:1513–1520PubMedCrossRef
27.
Steinman MA, Hanlon JT (2010) Managing medication in clinically complex elders. JAMA 304:1592–1601PubMedCrossRef
28.
Studenski S, Perera S, Patel K et al (2011) Gait speed and survival in older adults. JAMA 305:50–58PubMedCrossRef
29.
Vass M, Hendriksen C (2005) Polypharmacy and older people. Z Gerontol Geriatr 38(Suppl 1):I/14–I/17CrossRef
30.
Williams A, Manias E, Walker R (2008) Interventions to improve medication adherence in people with multiple chronic conditions: a systematic review. J Adv Nurs 63:132–143PubMedCrossRef
31.
Woodard LD, Landrum CR, Urech TH et al (2012) Treating chronically ill people with diabetes mellitus with limited life expectancy; implications for performance measurement. J Am Geriatr Soc 60:193–201PubMedCrossRef
Metadaten
Titel
Tools in polypharmacy
Current evidence from observational and controlled studies
verfasst von
Dr. P. Dovjak
Publikationsdatum
01.08.2012
Verlag
Springer-Verlag
Erschienen in
Zeitschrift für Gerontologie und Geriatrie / Ausgabe 6/2012
Print ISSN: 0948-6704
Elektronische ISSN: 1435-1269
DOI
https://doi.org/10.1007/s00391-012-0362-y

Weitere Artikel der Ausgabe 6/2012

Mitteilungen der ÖGGG

  • Mitteilungen der ÖGGG

Ethik in der Geriatrie

  • CME Zertifizierte Fortbildung

Neue orale Antikoagulanzien zur Schlaganfallprävention

  • Übersichten

Journal Club

  • Journal Club

Polypharmacy and incontinence

  • Beiträge zum Themenschwerpunkt

Erratum to: Palliative care for the geriatric patient in Europe. Survey describing the services, policies, legislation, and associations

  • Erratum